| Data set | Procedure | What's in this data set | Panel | Sex | Age (weeks) | Year |
|---|---|---|---|---|---|---|
|
|
urinalysis | Microalbumin, creatinine, ratio. | inbred w/CC7 (34) | m | 10wks | 2012 |
|
|
urinalysis | Microalbumin, creatinine, ratio. | CC pre w/par (163) | m | 10wks | 2012 |
|
|
study archive | Urinalysis. Creatinine, microalbumin, body weight. | QTL population | m | 8-10wks | 2008 |
|
|
study archive | eQTL, urinary albumin excretion using microarray. | QTL population | m | 8-10wks | 2011 |
|
|
urinalysis
with DB289 |
Urine volume, creatinine. DB289-treated vs. control. | inbred (34) | f | 6-8wks | 2012 |
|
|
biomarker quantification
with DB289 |
Kidney injury molecule 1 (KIM-1). DB289-treated vs. control. | inbred (34) | f | 6-8wks | 2012 |
|
|
urinalysis | Microalbumin, creatinine, ratio. | CC (18) | both | various | 2018 |
|
|
urinalysis | Microalbumin, creatinine, ratio. | KOMP | both | 8-18wks | 2021 |
|
|
urinalysis | Microalbumin, creatinine, ratio. Aging study, 6mo, 12mo, and 20mo. | inbred (30) | both | 52, 78, 104 wks | 2008 |
|
|
study archive | Urinalysis. Creatinine, microalbumin, body weight. | QTL population | m | 10wks | 2007 |
|
|
metabolite quantification
with arsenic |
iAs quantification in urine and liver, at 24 and 26 wks after iAs exposure. IAs speciation evaluated specifically monomethyl-arsenic acid (MMA) and dimethyl-arsenic acid (DMA) | DO population | m | 4-34 wks | 2022 |